Fisetin
Idiopathic Pulmonary Fibrosis · Senolytics
Clinical trials
1
Mechanism
Senolytics
Developer
Multiple
Overview
Fisetin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via senolytics. It appears in 1 tracked IPF clinical trial.
Fisetin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Fisetin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.